Techworm

-
Samsung Galaxy S25 series is expected to make its debut early next year. Rumour mills hint towards major changes coming to Samsung's flagship smartphone lineup in terms of hardware. The latest leak comes courtesy of a tipster who has shared images of the alleged cases of the Galaxy S25 series. The images suggest a shift in the design strategy of the purported top-of-t... from Gadgets 360 https://ift.tt/y8UWjcI
Post a Comment

Sixteen Chinese COVID-19 vaccines undergoing clinical trials for national, global supply

-

As the demand for the COVID-19 vaccine intensified around the world, China said that it has increased the number of vaccines undergoing clinical trials to 16 from 11 to step up supplies at home and abroad. China is conducting clinical trials of 16 COVID-19 vaccines, seven of which have entered phase-III trials and one has conditionally hit the market, Wu Yuanbin, an official with the Ministry of Science and Technology, was quoted as saying by the state-run CGTN TV.

Wu made the comments during a haematology conference on Saturday.

Yang Sheng, Deputy Director of China's National Medical Products Administration's drug registration bureau, said last month that a total of 11 Chinese vaccine candidates are in different stages of testing at home and abroad.

Currently, China is vaccinating people at home and some countries abroad with two vaccines. The Chinese government has given conditional approval to Sinopharm while the results of the phase-3 trial is yet to be released.

The World Health Organisation (WHO) is reviewing the trials of both the vaccines.

China has said that so far 46 countries have expressed their desire to import the China-made vaccines.

Respiratory-disease expert Zhong Nanshan said on Sunday that the mass inoculation of homegrown COVID-19 vaccines underway in China shows the vaccines are safe and effective.

The two vaccines currently in use in China – the China National Biotec Group (CNBG) COVID-19 vaccine and the CoronaVac vaccine developed by China's Sinovac Biotech Ltd – are both inactivated vaccines that are relatively safe, Zhong said at the launch ceremony of an event in south China's Guangdong province.

According to the Chinese Centre for Disease Control and Prevention (China CDC), more than 24 million doses of the COVID-19 vaccine had been administered in China till Sunday, state-run Xinhua news agency reported.

"The rate of the vaccines' mild adverse reactions, which include fever, soar arms and other symptoms, is six per 100,000 people," Zhong said.

The rate of severe adverse vaccine reactions is one in a million, only one third of that of flu vaccines, he said.



from Firstpost Tech Latest News https://ift.tt/3pB5gut

Comments

Post a Comment

Popular posts from this blog

Best phones under Rs 15,000 (Jan 2024): Poco X5 5G, Motorola G54 5G to Realme Narzo 60X 5G

-
Image
In a budget of Rs 15,000, one starts to see smartphones with features like AMOLED displays, 120Hz refresh rate and the arrival of 5G. In addition to that the processors start to get more powerful and the storage more generous. Just like last quarter, all the phones in this list are 5G-ready, and courtesy of the Republic Day sales, we also have a couple of options with 256GB internal storage. Time to look at who made it to our list of phones under Rs 15,000 this month. Best phones to buy under Rs 15,000 in India Poco X5 5G The Poco X5 5G remains a great all-round option under 15K, thanks to its well-rounded feature set, and you now get its 256GB storage variant in this budget. This phone is powered by a Qualcomm Snapdragon 695 chip and you get 8GB RAM with it. This phone flaunts a 6.67-inch Full HD+ Super AMOLED display with a peak brightness of 1200 nits and 120Hz refresh rate; a rare combination in this budget. The screen is protected against scratches by a layer of Corning Gorilla
Read more

Racial slurs on Twitter increased by 500 per cent after Elon Musk took over, platform blames trolling campaign

-
Image
Elon Musk finally took control of Twitter last week after buying it for a record $44 billion, one of the highest amounts anyone has ever paid in a tech acquisition. When Elon made the original offer to buy Twitter, Musk said that he is a free-speech absolutist . Musk and his fans had positioned him as an entity that would safeguard free speech at all costs. Well, it turns out, people really put that theory to the test. As per a report by The Washington Post, the use of certain derogatory epithets for African-Americans, Jews, and East Asians increased by up to 500 per cent on the platform, once news broke of Elon Musk taking over Twitter and firing most of its executive command, including CEO Parag Agarwal . The Network Contagion Research Institute (NCRI), a research group based out of Princeton, that analyzes social media content to predict emerging threats, said that the use of the N-word on Twitter increased by nearly 500 per cent in the 12 hours immediately after Musk’s deal was
Read more

Apple pays Russia a fine of $13.7 million, imposed for abusing its dominant position on the App Store

-
Apple has settled a Russian fine of 1.2 billion roubles ($13.65 million), according to Russia’s FAS antitrust agency. The fine was imposed due to allegations of Apple abusing its dominant market position in relation to in-app payments, as per a report by Reuters. Apple had previously expressed a “respectful disagreement” with the FAS ruling, contending that the distribution of apps through its iOS operating system did not unfairly favour its products. Russia’s anti-monopoly watchdog, FAS, announced on Monday that it received the payment following a November ruling. The ruling found Apple guilty of preventing app developers from informing customers that they could make purchases outside of the App Store. The payment will contribute directly to the Russian budget, supporting the government’s financial needs amid increased defense spending related to the conflict in Ukraine. This dispute between Apple and Russia’s competition regulator predates the invasion of Ukraine in February 2022
Read more